| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9646 |
| Human Intestinal Absorption | HIA+ | 0.9945 |
| Caco-2 Permeability | Caco2+ | 0.7497 |
| P-glycoprotein Substrate | Non-substrate | 0.8248 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9551 |
| Non-inhibitor | 0.9339 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8803 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4905 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8513 |
| CYP450 2D6 Substrate | Non-substrate | 0.7496 |
| CYP450 3A4 Substrate | Non-substrate | 0.6473 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7500 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8796 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8777 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8803 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9339 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8241 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9845 |
| Non-inhibitor | 0.9586 |
| AMES Toxicity | Non AMES toxic | 0.8449 |
| Carcinogens | Non-carcinogens | 0.5181 |
| Fish Toxicity | High FHMT | 0.9122 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9764 |
| Honey Bee Toxicity | Low HBT | 0.5669 |
| Biodegradation | Ready biodegradable | 0.6275 |
| Acute Oral Toxicity | III | 0.7035 |
| Carcinogenicity (Three-class) | Non-required | 0.5507 |